204 related articles for article (PubMed ID: 19958766)
1. D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window.
Adeleye A; Shohami E; Nachman D; Alexandrovich A; Trembovler V; Yaka R; Shoshan Y; Dhawan J; Biegon A
Eur J Pharmacol; 2010 Mar; 629(1-3):25-30. PubMed ID: 19958766
[TBL] [Abstract][Full Text] [Related]
2. D-cycloserine improves functional recovery and reinstates long-term potentiation (LTP) in a mouse model of closed head injury.
Yaka R; Biegon A; Grigoriadis N; Simeonidou C; Grigoriadis S; Alexandrovich AG; Matzner H; Schumann J; Trembovler V; Tsenter J; Shohami E
FASEB J; 2007 Jul; 21(9):2033-41. PubMed ID: 17351125
[TBL] [Abstract][Full Text] [Related]
3. Novel approach to the role of NMDA receptors in traumatic brain injury.
Shohami E; Biegon A
CNS Neurol Disord Drug Targets; 2014; 13(4):567-73. PubMed ID: 24168367
[TBL] [Abstract][Full Text] [Related]
4. Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice.
Wlaź P; Baran H; Löscher W
Eur J Pharmacol; 1994 May; 257(3):217-25. PubMed ID: 8088343
[TBL] [Abstract][Full Text] [Related]
5. Intrathecally administered D-cycloserine produces nociceptive behavior through the activation of N-methyl-D-aspartate receptor ion-channel complex acting on the glycine recognition site.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Furuta S; Sato T; Satoh S; Yasuhara H; Tadano T
J Pharmacol Sci; 2007 May; 104(1):39-45. PubMed ID: 17452810
[TBL] [Abstract][Full Text] [Related]
6. NMDA receptor in conditioned flavor-taste preference learning: blockade by MK-801 and enhancement by D-cycloserine.
Golden GJ; Houpt TA
Pharmacol Biochem Behav; 2007 Mar; 86(3):587-96. PubMed ID: 17350084
[TBL] [Abstract][Full Text] [Related]
7. The glycine/NMDA receptor partial agonist D-cycloserine blocks kainate-induced seizures in rats. Comparison with MK-801 and diazepam.
Baran H; Löscher W; Mevissen M
Brain Res; 1994 Aug; 652(2):195-200. PubMed ID: 7953730
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D
Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
[TBL] [Abstract][Full Text] [Related]
9. Chronic, post-injury administration of D-cycloserine, an NMDA partial agonist, enhances cognitive performance following experimental brain injury.
Temple MD; Hamm RJ
Brain Res; 1996 Nov; 741(1-2):246-51. PubMed ID: 9001729
[TBL] [Abstract][Full Text] [Related]
10. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
Trevisan L; Petrakis IL; Pittman B; Gueorguieva R; D'Souza DC; Perry E; Limoncelli D; Krystal JH
Alcohol Clin Exp Res; 2008 Jan; 32(1):36-42. PubMed ID: 18028532
[TBL] [Abstract][Full Text] [Related]
11. NRX-101, a Rapid-Acting Anti-Depressant, Does Not Cause Neurotoxicity Following Ketamine Administration in Preclinical Models.
Jordan W; Sapko MT; Siegel R; Javitt J
Int J Toxicol; 2023; 42(5):379-385. PubMed ID: 37226048
[TBL] [Abstract][Full Text] [Related]
12. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
Wlaź P
Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291
[TBL] [Abstract][Full Text] [Related]
13. Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits.
Biegon A; Fry PA; Paden CM; Alexandrovich A; Tsenter J; Shohami E
Proc Natl Acad Sci U S A; 2004 Apr; 101(14):5117-22. PubMed ID: 15044697
[TBL] [Abstract][Full Text] [Related]
14. Glycine and D: -serine, but not D: -cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801.
Kanahara N; Shimizu E; Ohgake S; Fujita Y; Kohno M; Hashimoto T; Matsuzawa D; Shirayama Y; Hashimoto K; Iyo M
Psychopharmacology (Berl); 2008 Jun; 198(3):363-74. PubMed ID: 18437299
[TBL] [Abstract][Full Text] [Related]
15. D-Cycloserine Restores Experience-Dependent Neuroplasticity after Traumatic Brain Injury in the Developing Rat Brain.
Sta Maria NS; Reger ML; Cai Y; Baquing MAT; Buen F; Ponnaluri A; Hovda DA; Harris NG; Giza CC
J Neurotrauma; 2017 Apr; 34(8):1692-1702. PubMed ID: 27931146
[TBL] [Abstract][Full Text] [Related]
16. Modulatory effects of an NMDAR partial agonist in MK-801-induced memory impairment.
Vishnoi S; Raisuddin S; Parvez S
Neuroscience; 2015 Dec; 311():22-33. PubMed ID: 26454025
[TBL] [Abstract][Full Text] [Related]
17. Stress and a glycinergic intervention interact in the modulation of MK-801-elicited mouse popping behavior.
Deutsch SI; Rosse RB; Schwartz BL; Powell DG; Mastropaolo J
Pharmacol Biochem Behav; 1999 Feb; 62(2):395-8. PubMed ID: 9972709
[TBL] [Abstract][Full Text] [Related]
18. Effects of activation and blockade of NMDA receptors on the extinction of a conditioned passive avoidance response in mice with different levels of anxiety.
Tomilenko RA; Dubrovina NI
Neurosci Behav Physiol; 2007 Jun; 37(5):509-15. PubMed ID: 17505804
[TBL] [Abstract][Full Text] [Related]
19. NMDA receptor antagonist MK-801 reduces neuronal damage and preserves learning and memory in a rat model of traumatic brain injury.
Han RZ; Hu JJ; Weng YC; Li DF; Huang Y
Neurosci Bull; 2009 Dec; 25(6):367-75. PubMed ID: 19927173
[TBL] [Abstract][Full Text] [Related]
20. D-cycloserine injected into the dorsolateral periaqueductal gray induces anxiolytic-like effects in rats.
Gomes FV; Kakihata AM; Semedo AC; Hott SC; Uliana DL; Guimarães FS; Resstel LB
Behav Brain Res; 2014 Sep; 271():374-9. PubMed ID: 24931794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
